• No results found

EVALUATION OF ANTI ULCER ACTIVITY OF PLATYCODON GRANDIFLORUM A DC ON MUCOSAL LESION IN RAT

N/A
N/A
Protected

Academic year: 2020

Share "EVALUATION OF ANTI ULCER ACTIVITY OF PLATYCODON GRANDIFLORUM A DC ON MUCOSAL LESION IN RAT"

Copied!
20
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1: A score for the ulcer was made as follows.
Fig 1: Normal group (without treatment). Fig 2: Control group (Normal saline 10ml/kg)
Table: 3 Effect of methanolic extract of Platycodon grandiflorum A.DC plant on aspirin
Fig 7: Anti-ulcer effect of methanolic extract of  Treatment Platycodon grandiflorum A.DC ongastric juice in Aspirin plus pylorus ligation induced ulcer models in rats
+2

References

Related documents

Der AID-Level ist in den ersten vier Stunden nach der EBNA2 Induktion sehr stark abgefallen (Abb.10A) und erreichte dann wieder einen.. ohne Östrogen kultiviert. A ) Die

When treating lower body functioning as a continuous measure and adjusting for age, gender, and study site, the correlates of better functioning that we identified were younger

To detect translational dysfunction in our brain lesion model after six weeks of differentiation we performed ribosome profiling, which allows quantifica- tion of dynamic changes

• Since posts do not reinforce endodontically treated teeth, they are indicated only when there is inadequate tooth structure to retain a core; however, preparation of a post

The main objective was to establish the validity of self-measurement of waist and hip circumference in a community setting and the correlation of those measures with BMI,

Collected patient characteristics included age, insur- ance coverage type, indication for anticoagulation, dura- tion of warfarin therapy, date of most recent DUHS healthcare visit,

Conclusions: Although total blood loss and transfusion rate can be high, this preliminary case series suggested that the one-stage bilateral TKA in ASA class 1 or 2 patients can

Several institutions (for example, the United States Food and Drug Administration (FDA), the European Medi- cines Agency (EMA), and the Australian Therapeutic Goods